Salvia BioElectronics Receives FDA Breakthrough Designation For Neurostimulator To Treat Chronic Migraine
Executive Summary
The Dutch start-up said it will work with the FDA to accelerate the development of its neurostimulator for treating chronic migraine. There are no approved implantable devices on the market for treating chronic migraine.